Orexo eyes real-world testing of its modia opioid use disord...

Orexo will start a new study of its modia app – used to treat people with opioid use disorder – to test how it performs in real-world settings.

Orexo eyes opioid use disorder app launch before year-end

Sweden’s Orexo says its opioid use disorder (OUD) digital therapeutic – now christened Modia – is on course for a launch before the end of the year in the US.

Orexo launches digital therapies for depression, alcohol mis...

Sweden’s Orexo has launched two digital therapies in the US earlier than expected, following changes to US regulations that allow early access during the COVID-19 crisis.

Orexo partners with Lyfebulb to study addiction during pande...

With drinking and drug use said to be spiking during the pandemic, Orexo has teamed up with US organisation Lyfebulb to research how the crisis is affecting people with addicti

Orexo buys US rights to GAIA's deprexis digital therapeutic

Sweden's Orexo has announced it has bought the exclusive US rights to GAIA’s deprexis, a digital therapy to help patients manage their symptoms of depression and one of the most researched

Orexo eyes launch of digital therapy for heavy drinkers this...